Optimum Antithrombotic Therapy in Patients Requiring Long-Term Anticoagulation and Undergoing Percutaneous Coronary Intervention

BioMed Research International
Nayan AgarwalAhmed N Mahmoud

Abstract

Management of patients on long-term anticoagulation requiring percutaneous coronary intervention is challenging. Triple therapy with oral anticoagulant and dual antiplatelet therapy is the standard of care. However, there is no strong evidence to support this strategy. There is emerging data regarding the safety and efficacy of dual therapy with oral anticoagulant and single antiplatelet therapy in these patients. In this comprehensive review we highlight available evidence regarding various antithrombotic regimens' efficacy and safety in patient with coronary artery disease undergoing percutaneous coronary intervention with long-term anticoagulation therapy requirements.

References

Apr 2, 2004·Circulation Journal : Official Journal of the Japanese Circulation Society·Koji KumagaiKunio Shirato
Aug 31, 2004·Journal of Thrombosis and Haemostasis : JTH·W E WysokinskiR D McBane
Feb 3, 2007·European Heart Journal·Pasi P KarjalainenK E Juhani Airaksinen
Oct 20, 2007·Lancet Neurology·Gregory Y H Lip, Hoong Sern Lim
May 30, 2009·Journal of the American College of Cardiology·Brendan J DoyleDavid R Holmes
Jan 12, 2010·Thrombosis and Haemostasis·Gregory Y H LipUNKNOWN European Society of Cardiology Working Group on Thrombosis
Mar 9, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Fei GaoMiao Yu
Apr 27, 2011·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Jonas PerssonAnn Samnegard
Nov 11, 2011·The New England Journal of Medicine·Laurent Fauchier, Nicolas Clementy
Nov 15, 2011·The New England Journal of Medicine·Jessica L MegaUNKNOWN ATLAS ACS 2–TIMI 51 Investigators
Nov 28, 2012·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Tara GomesDavid N Juurlink
Mar 14, 2013·JAMA : the Journal of the American Medical Association·Adnan K ChhatriwallaUNKNOWN National Cardiovascular Data Registry
Jun 12, 2013·Journal of the American College of Cardiology·Morten LambertsMorten Lock Hansen
Sep 23, 2014·Journal of the American College of Cardiology·Willem J M DewildeJurriën M Ten Berg
Apr 25, 2015·Journal of the American College of Cardiology·Katrin A FiedlerNikolaus Sarafoff
Jan 23, 2016·The American Journal of Medicine·Renato D LopesKenneth W Mahaffey
Dec 14, 2016·The New England Journal of Medicine·C Michael GibsonKeith A Fox

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT02415400

Software Mentioned

WOEST
AUGUSTUS
PIONEER
RT
AF

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.